CYP2C19*2predicts substantial tamoxifen benefit in...

Breast Cancer Research and Treatment 2013 / 06 Vol. 139; Iss. 3

CYP2C19*2predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment

K. Beelen, M. Opdam, T. M. Severson, R. H. T. Koornstra, A. D. Vincent, M. Hauptmann, R. H. N. van Schaik, E. M. J. J. Berns, J. B. Vermorken, P. J. van Diest, S. C. Linn…show all 11hide
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
139
Language:
english
DOI:
10.1007/s10549-013-2568-0
Date:
June, 2013
File:
PDF, 263 KB
english, 2013
Conversion to is in progress
Conversion to is failed